Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in hemodialysis patients

Kidney International

Volumn 76, Issue 4, 2009, Pages 428-436

  De Vriese, An S ^a   De Bacquer, Dirk A ^b   Verbeke, Francis H ^b   De Winter, Olivier ^b   Franken, Philippe R ^c   De Sutter, Johan H ^b   Walgraeve, Natascha ^d   Missault, Luc ^d   De Geeter, Frank W ^d  

^a Renal Unit   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^d NONE   (Belgium)

Author keywords

Coronary artery disease; Dipyridamole; Dobutamine; Hemodialysis; Myocardial perfusion scintigraphy; Prognostic

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DRUG TOLERABILITY; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART STRESS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; DIPYRIDAMOLE; DOBUTAMINE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; RENAL DIALYSIS; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 68249093384     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.160     Document Type: Article

References (25)

1. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 1994; 25: 653-659.
2. Ohtake T, Kobayashi S, Moriya H et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148.
3. Joki N, Hase H, Nakamura R et al. Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723.
4. Braun WE, Philips DF, Vidt DG. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 1984; 16: 603-607.
5. Manske C, Wang Y, Rector T et al. Coronary revascularization in insulin dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998-1002.
6. Yasuda K, Kasuga H, Aoyama T et al. Comparison of Percutaneous Coronary Intervention with Medication in the Treatment of Coronary Artery Disease in Hemodialysis Patients. J Am Soc Nephrol 2006; 17: 2322-2332.
7. Rabbat CG, Treleaven DJ, Russell D et al. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003; 14: 431-439.
8. Brown KA, Rimmer J, Haisch C. Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 1989; 64: 1017-1021.
9. Fuster D, Magriñá J, Ricart MJ et al. Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy. Transpl Int 2000; 13: 327-332.
10. Dahan M, Viron BM, Faraggi M et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 1998; 54: 255-262.
11. Derfler K, Kletter K, Balcke P et al. Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 1991; 36: 192-202.
12. Feola M, Biggi A, Ribichini F et al. Predicting cardiac events with TL201 dipyridamole myocardial scintigraphy in renal transplant recipients. J Nephrol 2002; 15: 48-53.
13. Schmidt A, Stefenelli T, Schuster E et al. Informational contribution of non-invasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 2001; 37: 56-63.
14. Marwick TH, Steinmuller DR, Underwood DA et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990; 49: 100-103.
15. Vandenberg BF, Rossen JD, Grover-McKay M et al. Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods. Transplantation 1996; 62: 1230-1235.
16. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991; 90: 563-570.
17. Bergeron S, Hillis GS, Haugen EN et al. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J 2007; 153: 385-391.
18. Herzog CA. Noninvasive diagnosis of CAD in patients with end-stage renal disease. In: Marwick TH (ed). Cardiac Stress Testing and Imaging. Churchill Livingstone: New York, 1996, pp 203-222.
19. Cortigiani L, Desideri A, Gigli G et al. Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates. Int J Cardiol 2005; 103: 168-174.
20. Marwick TH, Lauer MS, Lobo A et al. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 1998; 244: 155-161.
21. Camp AD, Garvin PJ, Hoff J et al. Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 1990; 65: 1459-1463.
22. Brown JH, Vites NP, Testa HJ et al. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 1993; 8: 433-437.
23. Le A, Wilson R, Douek K et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994; 24: 65-71.
24. Hachamovitch R, Hayes S, Friedman JD et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 2003; 41: 1329-1340.
25. Machin D, Cheung YB, Parmar MKB (eds). Survival Analysis: a practical approach. 2nd edn. John Wiley & Sons Ltd.: Chichester, 2006.